The Journal of Immunology, Vol 139, Issue 6 1861-1866, Copyright © 1987 by American Association of Immunologists

ARTICLES

The in vivo effects of interleukin 1. I. Bone marrow cells are induced to cycle after administration of interleukin 1

R Neta, MB Sztein, JJ Oppenheim, S Gillis and SD Douches

We have previously reported that interleukin 1 (IL-1) administration 20 hr before irradiation protects mice from lethal effects of radiation. The recovery of total nucleated bone marrow cells and of hematopoietic progenitor cells was enhanced in IL-1 treated, as compared to untreated, irradiated mice. This suggested that IL-1 administration may affect the cells in the bone marrow of normal mice. Intraperitoneal administration of recombinant IL-1 resulted in bone marrow cell enlargement and increased cycling of these enlarged cells. In addition, the capacity of bone marrow cells from IL-1 treated mice to proliferate in response to granulocyte macrophage-colony-stimulating factor (GM- CSF) in cell suspension cultures was enhanced. The above effects were not genetically restricted as C57BL/6, B6D2F1, C3H/HeN, and C3H/HeJ mice showed similar responses. A comparative study showed that 100 ng of IL-1 was much more effective in stimulating bone marrow cells by the above criteria than 5 micrograms GM-CSF. Since IL-1, unlike CSF, can not be demonstrated to have a direct in vitro stimulatory effect on bone marrow cells, the aforementioned in vivo effects of IL-1 are presumably mediated by other hematopoietic growth factors. We have previously shown that IL-1 induces the appearance of high titers of CSF in the serum. Consequently hematopoietic growth factors that are generated at local sites following IL-1 administration may mediate the observed cell cycling effect.

This article has been cited by other articles:

				R. V. Gardner, E. McKinnon, C. Poretta, and L. Leiva Hemopoietic Function After Use of IL-1 with Chemotherapy or Irradiation J. Immunol., August 1, 2003; 171(3): 1202 - 1206. [Abstract] [Full Text] [PDF]